Company intelligence / Profile preview

Ferring Ventures

Kuopio, Pohjois-Savo, Finlandkct.fi ↗

Ownership: Private
Employees: ~27
Development stage: Commercial

Overview

Ferring Ventures Oy conducts high-level translational research in cell and gene therapy. Its programs are primarily at the discovery or early translational stage. The company develops advanced manufacturing processes and analytics for ATMPs. It collaborates closely with academic partners to move promising therapies toward clinical trials. No late-stage or commercialized products are reported as of 2025

Therapeutic areas: OncologyImmunology
Modalities: Cell therapyGene therapy
Industry: Biotech

Partnerships

University of Eastern Finland/A.I. Virtanen Institute/National Laboratory Animal Center/Kuopio University Hospital’s Gene Therapy UnitFinVector Oy & FKD Therapies Oy share campus/collaborative history

Beyond the preview

Go deeper on Ferring Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferring Ventures.

Explore the full profile